Notice of Syensqo’s Annual General Meeting on May 23, 2024
Notice of Syensqo’s Annual General Meeting on May 23, 2024
Brussels, Belgium – April 23, 2024 - 08.30 CEST
Syensqo, today announced that it has published materials for its first Ordinary General Shareholders’ Meeting, which will be held on Thursday May 23, 2024 at the Dome EventHall, Boulevard Lambermont 1, 1000 Brussels, at 10.30 a.m. CEST. All documents relating to the meeting are available on Syensqo’s website.
Shareholders will be asked to vote on a number of resolutions, including the approval of Syensqo’s financial statements for the financial year 2023 and the remuneration of non-executive directors from January 1, 2024.
Following the Company’s continued strong cash generation in 2023, which supported the further deleveraging of its balance sheet, Syensqo’s Board of Directors will also propose to approve the distribution of a total gross dividend of €1.62 per share.
In addition, shareholders will be asked to approve the appointment of a statutory auditor with the responsibility of certifying Syensqo’s Sustainability Report, as required by the Corporate Sustainability Reporting Directive (CSRD).
Meeting information
Only shareholders of Syensqo SA who are officially recorded as such on May 9, 2024 at midnight CEST will have the right to participate and vote at the meeting on May 23 irrespective of the number of shares they hold on the day of the meeting.
Shareholders who wish to participate at the meeting, either in-person or virtually, should declare their intentions no later than on May 17, 2024 and are required to follow the instructions indicated in the convening notice available on Syensqo’s website.
The meeting will be organized in a hybrid manner, both in person and virtually. Shareholders can participate physically in the Meeting. Alternatively, Shareholders may exercise their rights through a proxy vote or vote by correspondence through a dedicated form or participating and voting live in a virtual and interactive manner. Shareholders can use the Lumi Connect platform (www.lumiconnect.com) or contact directly Syensqo team at ag@syensqo.com to complete the participation formalities. A document explaining the different steps to follow for the use of the Lumi Connect platform will be available on Syensqo’s website.
All questions can be addressed to ag@syensqo.com by May 17, 2024 the latest.
Visit the Shareholders’ Meeting dedicated page for more details regarding the agenda, the admission conditions and voting methods.
Media relations media.relations@syensqo.com Perrine Marchal +32 478 32 62 72 Laetitia Schreiber +32 487 74 38 07 | Investor Relations investor.relations@syensqo.com Sherief Bakr +44 7920 575 989 Bisser Alexandrov +33 6 07 63 52 80 Imtiyaz Lokhandwala +1 609 860 3959 |
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release
Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r
NGS Group AB: NGS Group offentliggör utfall i riktad emission om 16,1 MSEK3.5.2024 18:00:00 CEST | Pressemelding
NGS Group AB:s (publ) (”NGS Group” eller ”Bolaget”) nyemission av aktier riktad till strategiska investerare om cirka 16,1 MSEK, före emissionskostnader (den ”Riktade Emissionen”) som beslutades av styrelsen den 29 februari 2024 och godkändes av den extra bolagsstämman den 26 mars 2024, har tecknats med totalt 4 962 577 aktier. Genom den Riktade Emissionen tillförs Bolaget cirka 16,1 MSEK, före avdrag för emissionskostnader. Utfall i den Riktade Emissionen Hugo Lewné och Nils Sjögren har tecknat och tilldelats totalt 4 962 577 aktier motsvarande cirka 16,1 MSEK i den Riktade Emissionen. Storleken på den Riktade Emissionen styrdes av teckningsgraden i den nyemission av aktier med företrädesrätt för befintliga aktieägare om ca 35,2 MSEK, före emissionskostnader (”Företrädesemissionen” och tillsammans med den Riktade Emissionen ”Emissionerna”) vari slutligt utfall offentliggjordes den 29 april 2024. Då Företrädesemissionen övertecknades innebär det att den Riktade Emissionens omfattning ä
Bulletin from BTS Group AB's Annual General Meeting3.5.2024 17:34:40 CEST | Press release
Stockholm May 3, 2024 The Annual General Meeting approved the proposed dividend to shareholders of SEK 5,70 per share, divided into two payment occasions of SEK 2,85 each. The record date for the first payment of SEK 2,85 was determined to Tuesday May 7, 2024 and for the second payment of SEK 2,85 was determined to Wednesday November 13, 2024. The first payment is expected to be made on Monday May 13, 2024 and the second payment is expected to be made on Monday November 18, 2024. The Annual General Meeting discharged the members of the Board of Directors and the CEO from liability for the financial year 2023 and approved the remuneration report for 2023 prepared by the Board of Directors. The Annual General Meeting approved the remuneration to board members to a total of SEK 1,735,000, of which SEK 525,000 to the Chairman and SEK 235,000 to each of the other board members, and SEK 60,000 to the Deputy Board member. A total fee of SEK 225,000 shall be paid for committee work. Mariana Bu
Kommuniké från BTS Group ABs årsstämma3.5.2024 17:34:40 CEST | Pressemelding
Stockholm 3 maj 2024 Årsstämman fastställde föreslagen utdelning till aktieägarna om 5,70 kronor per aktie, uppdelat på två utbetalningstillfällen om vardera 2,85 SEK. Som avstämningsdag för den första utbetalningen om 2,85 SEK fastställdes tisdagen den 7 maj 2024 och för den andra utbetalningen om 2,85 SEK fastställdes onsdagen den 13 november 2024. Den första utbetalningen beräknas ske måndagen den 13 maj 2024 och den andra utbetalningen beräknas ske måndagen den 18 november 2024. Årsstämman beviljade styrelseledamöterna och verkställande direktören ansvarsfrihet för verksamhetsåret 2023 samt godkände den av styrelsen upprättade ersättningsrapporten för 2023. Årsstämman fastställde arvodet till styrelseledamöter till totalt 1 735 000 kronor, varav 525 000 kronor till ordföranden och 235 000 kronor till respektive övrig styrelseledamot, samt 60 000 kronor till styrelsesuppleanten. För utskottsarbete skall ett totalt arvode om 225 000 kronor utgå. Mariana Burenstam Linder, Stefan Garde
Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer3.5.2024 17:32:16 CEST | Press release
Wistar’s Veglia lab identified how glioblastoma evades the immune system by inducing pro-tumor macrophages via a glucose based epigenetic modification. PHILADELPHIA, PA, May 03, 2024 (GLOBE NEWSWIRE) -- The Wistar Instituteassistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune system so that the tumor can grow unimpeded by the body’s defenses. The lab’s discovery was published in the paper, “Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma,” in the journal Immunity. “Our study shows that the cellular mechanisms of cancer’s self-preservation, when sufficiently understood, can be used against the disease very effectively,” said Dr. Veglia. “I look forward to future research on metabolism-driven mechanisms of immunosuppression in glioblastoma, and I’m hopeful for all that we will continue to learn about